A novel genetic-based therapeutic platform for eradicating Metastatic cancer
We developed a therapeutic platform for eliminating a wide range of metastatic
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
We developed a therapeutic platform for eliminating a wide range of metastatic
breast cancer either benign or malignant. Supervised learning algorithm Support Vector Machine (SVM) with kernels like Linear, Polynomial and Radial Basis Function and evolutionary algorithm Genetic Programming are used…
year survival rate for colorectal cancer is ~60-65% in North America. Stage of the disease and age of the patient at the time of diagnosis are well-known prognostic ... Cancer Registry (NFCCR), our laboratory focuses on…
were treated in the Lviv Regional State Cancer Diagnostic Center from June 2008 to December 2012. Molecular-genetic method determined the presence of seven mutations in the gene BRCA1 (185delAG ... mutations BRCA1/2…
function of every gene in the entire genome to find genetic synthetic lethal interactions between non-cancer genes and bona-fide cancer genes. The use of our pioneering RNA interference ... RNAi) technology to exanimate…
alcoholism, cigarette smoking, obesity and CYP2E1 RsaI and 96-bp insertion genetic polymorphisms with risk for colorectal cancer (CRC). Patients with CRC (70 women and 61 men) were matched ... alcoholism, cigarette…
Recent studies of genetically engineered stem cells (GESTECs) have received a great deal of attention as an alternative potent anti-tumor treatment to various human cancers. In this study, human
factors for pancreatic cancer. Risk factors for pancreatic cancer can be classified into three broad categories: demographic, environmental (host), and hereditary (genetic) predisposition. This manuscript will review…
Hereditary cancer, driven by genetic predispositions, has significantly transformed the landscape of cancer treatment through the advent of personalized medicine. This paper explores the integration of genetic…
ductal carcinoma in situ begins with an initial assessment of familial/genetic factors associated with increased breast cancer risk for the purpose of determining whether more extensive genetic risk assessment…
Background: Cancer comorbidity with lung diseases is evident from epidemiological and clinical data. Fatality relationships analysis is tough to check intimately victimization by using conventional ... endocrinological…
interference of environmental factors and genetic disorders. Among of the key genes involved in the guidance of cancer cells can be mentioned to Oncogenes, tumor suppressor genes, restorative genes ... prognosis that…
direction of cancer and out of which, the frontier in line is the colorectal cancer (CRC) affecting both gender with women showing the higher mortality in comparison ... group of 65 and above. There are multiple sources…
Breast cancer is very common cancer worldwide. Estrogen is one of the
Colorectal Cancer (CRC) is a heterogeneous disease which leads to clinical and pathological diversity in tumors that result in genetic and biological heterogeneity. These diversity leads to see divergence ... specific…
We present a first in human case of a 50 year-old
hypothesis. The new hypothesis relates to the biological properties of the chemotherapy curable cancers which comprise trophoblast tumours, germ cell tumours, acute leukemia, high grade lymphoma, and the rare childhood…
For authors and organisers
Find the right journal for your paper and submit your manuscript.